Investment Thesis
Despite exceptional 12,900% revenue growth, Tivic Health faces existential financial challenges with negative gross margins (-13.6%), operating losses of $7.9M, and negative operating cash flow of $7.0M annually. With only $12.6M in cash and fundamental unit economics showing losses on every dollar of revenue generated, the company has approximately 1.8 years of runway at current burn rates without achieving profitability.
Strengths
- Exceptional top-line revenue growth of 12,900% YoY demonstrates strong market demand for products/services
- Strong balance sheet with zero long-term debt, $12.6M cash reserves, and 40% of assets in liquid form
- Excellent short-term liquidity with 20.13x current ratio indicating ability to meet near-term obligations
Risks
- Negative gross margins (-13.6%) indicate fundamental unit economics where revenue generation destroys value on every transaction
- Annual operating cash burn of -$7.0M against cash base of $12.6M provides limited survival runway of approximately 22 months
- No demonstrable path to profitability despite massive revenue growth, suggesting structural defects in business model rather than scale limitations
Key Metrics to Watch
- Gross margin trend - requires reversal to positive levels to validate business model viability
- Operating cash flow and cash runway depletion rate - critical indicator of company survival window
- Cost of goods sold as percentage of revenue - must show improvement trajectory toward positive contribution margins
Financial Metrics
Revenue
302.0K
Net Income
-8.9M
EPS (Diluted)
$-4.64
Free Cash Flow
-7.0M
Total Assets
31.6M
Cash
12.6M
Profitability Ratios
Gross Margin
-13.6%
Operating Margin
-2,615.2%
Net Margin
-2,939.7%
ROE
-52.9%
ROA
-28.1%
FCF Margin
-2,330.1%
Balance Sheet & Liquidity
Current Ratio
20.13x
Quick Ratio
20.13x
Debt/Equity
0.00x
Debt/Assets
23.5%
Interest Coverage
-15.89x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-17T11:48:24.767748 |
Data as of: 2025-12-31 |
Powered by Claude AI